MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Skincare
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
At 2016 Genesis Event, Kannaway® Unveils New Direction for World-Wide Brand

At 2016 Genesis Event, Kannaway® Unveils New Direction for World-Wide Brand

by adminTorusBrand | Nov 18, 2016 | Company News, Kannaway

This past weekend, Medical Marijuana, Inc. portfolio company Kannaway® relaunched its world-renowned brand to over 200 Brand Ambassadors at Genesis 2016, who traveled from around the world to attend our national conference near the company’s downtown San Diego,...
Report by StoneBridge Partners Reveals the Growing Market Value of Medical Marijuana, Inc.

Report by StoneBridge Partners Reveals the Growing Market Value of Medical Marijuana, Inc.

by adminTorusBrand | Nov 18, 2016 | Company News

A recent evaluation of Medical Marijuana, Inc. by the StoneBridge Partners private investment firm exposes the company’s significant market potential. In a 24 page report compiled by StoneBridge Partners and published November 15, 2016, the investment firm explored...
AXIM® Biotechnologies Patent on Delayed Release Cannabidiol Gum Extended to Include All Cannabinoids

AXIM® Biotechnologies Patent on Delayed Release Cannabidiol Gum Extended to Include All Cannabinoids

by adminTorusBrand | Nov 17, 2016 | Axim Biotechnologies, Company News

Medical Marijuana, Inc. investment company AXIM® Biotechnologies announced this week that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Application Serial Number 9,433,601, a patent owned by the company that claims the use...
U.S. Patent Allowance Granted to Medical Marijuana, Inc.’s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

U.S. Patent Allowance Granted to Medical Marijuana, Inc.’s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

by adminTorusBrand | Nov 16, 2016 | Axim Biotechnologies, Press Releases

SAN DIEGO, CA–(Marketwired – November 16, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its major investment AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM), a world leader in hemp cannabinoid research and development,...
Why Big Pharma is Scared of Cannabinoids – and How Medical Marijuana, Inc. is Bridging the Gap

Why Big Pharma is Scared of Cannabinoids – and How Medical Marijuana, Inc. is Bridging the Gap

by adminTorusBrand | Nov 11, 2016 | Axim Biotechnologies, Company News, Industry Updates, Kannalife Sciences

[vc_row][vc_column][vc_column_text]As cannabis continues to expand into a multi-billion dollar international market, other sectors of the economy are beginning to feel the effects of this new industry’s growth – none more so than pharmaceuticals. This raises an...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.